Abstract:Background: Breast cancer is the highest incidence of tumor in women, which seriously threaten women's health. The occurrence and progression of breast cancer is linked to inactivation or downregulation of tumor suppressors, and activation or upregulation of oncogenes. However, the mechanism of PAK7 involving in the occurrence and progression of breast cancer is not yet fully understood. Methods: PAK7 expression was analyzed by RT-qPCR and immunohistochemistry and correlated with clinicopatholgical parameters in breast cancer tissue microarray. The effects of PAK7 on breast cancer cells were detected by CCK-8 assay, colon formation assay, wound healing and transwell assays, and flow cytometry. The relationship between PAK7 and Wnt/beta-catenin signaling pathway was determined by western blotting, TOP/FOP flash, co-Immunoprecipitation and co-localization assays. Results: PAK7 expression was significantly increased in breast cancer tissues and positively correlated with pathological differentiation and TNM stage of breast cancer. Overexpression of PAK7 could significantly promote proliferation and migration of breast cancer cells, and inhibit apoptosis. In contrast, PAK7 knockdown significantly inhibited the proliferation and migration of breast cancer cells and promoted apoptosis. In addition, PAK7 could activate Wnt/beta-catenin signaling pathway in breast cancer cells. Further study found that PAK7 could directly bind to GSK3 beta and p-catenin, and regulate p-catenin degradation by phosphorylating GSK3 beta. Conclusions: Our study demonstrated that PAK7, as an oncogene, involved in breast cancer progression by activating the Wnt/beta-catenin signaling pathway, suggesting that the potential applicability of PAK7 as a target for breast cancer treatment.

P21-Activated Kinase 5 Inhibits Camptothecin-Induced Apoptosis in Colorectal Carcinoma Cells

PAK1-dependent MAPK Pathway Activation is Required for Colorectal Cancer Cell Proliferation

P21-Activated Kinase 5 is Overexpressed During Colorectal Cancer Progression and Regulates Colorectal Carcinoma Cell Adhesion and Migration

PAK5 Facilitates the Proliferation, Invasion and Migration in Colorectal Cancer Cells

P-21 Activated Kinase 1 Knockdown Inhibits Β-Catenin Signalling and Blocks Colorectal Cancer Growth.

P21-activated Kinase 1 Promotes Colorectal Cancer Survival by Up-Regulation of Hypoxia-Inducible Factor-1Α

Depletion of P21-Activated Kinase 1 Up-Regulates the Immune System of APC∆14/+ Mice and Inhibits Intestinal Tumorigenesis

PAK Inhibition by PF-3758309 Enhanced the Sensitivity of Multiple Chemotherapeutic Reagents in Patient-Derived Pancreatic Cancer Cell Lines.

High-level Expression of P21-Cdc/Rac-activated Kinase 7 is Closely Related to Metastatic Potential and Poor Prognosis of Colon Carcinoma.

Inhibition of Protein Phosphatase 5 (PP5) Suppresses Survival and Growth of Colorectal Cancer Cells

Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.

CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway

P21-Activated Kinases and Gastrointestinal Cancer

P21-activated Kinase 1 and 4 Were Associated with Colorectal Cancer Metastasis and Infiltration.

The PAK Inhibitor PF-3758309 Promotes the Inhibitory Effects of Multiple Chemotherapeutic Reagents on Patient-Derived Pancreatic Cancer Cell Lines

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer

[Clinicopathological Significance of Expression and Amplification of P21-activated Kinase 1 Gene in Colorectal Carcinoma].

P21-activated kinase 7 (PAK7) interacts with and activates Wnt/β-catenin signaling pathway in breast cancer.

PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy.

PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo

P21-activated Kinase 1 and Breast Cancer